Ülo Langel

28.2k total citations · 3 hit papers
437 papers, 21.8k citations indexed

About

Ülo Langel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Microbiology. According to data from OpenAlex, Ülo Langel has authored 437 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 372 papers in Molecular Biology, 139 papers in Cellular and Molecular Neuroscience and 47 papers in Microbiology. Recurrent topics in Ülo Langel's work include RNA Interference and Gene Delivery (220 papers), Advanced biosensing and bioanalysis techniques (187 papers) and Neuropeptides and Animal Physiology (126 papers). Ülo Langel is often cited by papers focused on RNA Interference and Gene Delivery (220 papers), Advanced biosensing and bioanalysis techniques (187 papers) and Neuropeptides and Animal Physiology (126 papers). Ülo Langel collaborates with scholars based in Sweden, Estonia and United States. Ülo Langel's co-authors include Tamás Bartfai, Margus Pooga, Mattias Hällbrink, Samir EL Andaloussi, Matjaž Zorko, Astrid Gräslund, Anna Elmquist, Kent Langel, Maria Lindgren and Pontus Lundberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ülo Langel

436 papers receiving 21.3k citations

Hit Papers

Mechanisms of Cellular Uptake of Cell-Penetrating Peptides 2005 2026 2012 2019 2011 2014 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ülo Langel Sweden 79 17.9k 4.8k 3.1k 2.3k 2.0k 437 21.8k
Alain Prochiantz France 68 12.6k 0.7× 7.9k 1.7× 972 0.3× 2.0k 0.9× 527 0.3× 204 19.1k
Harvey T. McMahon United Kingdom 73 19.3k 1.1× 4.2k 0.9× 304 0.1× 1.2k 0.5× 1.0k 0.5× 113 26.6k
Shiroh Futaki Japan 64 15.0k 0.8× 528 0.1× 2.1k 0.7× 2.8k 1.2× 2.2k 1.1× 330 17.4k
Erwin London United States 66 15.7k 0.9× 1.6k 0.3× 543 0.2× 754 0.3× 563 0.3× 192 19.3k
John E. Shively United States 74 9.8k 0.5× 2.3k 0.5× 546 0.2× 1.6k 0.7× 264 0.1× 420 20.1k
Annette G. Beck‐Sickinger Germany 66 9.7k 0.5× 5.8k 1.2× 672 0.2× 437 0.2× 643 0.3× 472 16.2k
Dick Hoekstra Netherlands 64 11.9k 0.7× 688 0.1× 396 0.1× 1.9k 0.8× 2.0k 1.0× 257 16.5k
Jack E. Dixon United States 99 24.8k 1.4× 3.9k 0.8× 412 0.1× 4.3k 1.8× 236 0.1× 347 35.7k
Daniel Scherman France 74 13.3k 0.7× 1.9k 0.4× 175 0.1× 4.3k 1.9× 1.7k 0.9× 418 24.2k
Paul F. Alewood Australia 68 12.8k 0.7× 2.0k 0.4× 1.7k 0.5× 2.6k 1.1× 278 0.1× 341 16.4k

Countries citing papers authored by Ülo Langel

Since Specialization
Citations

This map shows the geographic impact of Ülo Langel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ülo Langel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ülo Langel more than expected).

Fields of papers citing papers by Ülo Langel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ülo Langel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ülo Langel. The network helps show where Ülo Langel may publish in the future.

Co-authorship network of co-authors of Ülo Langel

This figure shows the co-authorship network connecting the top 25 collaborators of Ülo Langel. A scholar is included among the top collaborators of Ülo Langel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ülo Langel. Ülo Langel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mamashli, Fatemeh, Faezeh Moosavi-Movahedi, Ahmad Amiri, et al.. (2024). Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases. Molecular Pharmaceutics. 21(5). 2097–2117. 23 indexed citations
2.
Arukuusk, Piret, et al.. (2023). Aggregation Limiting Cell-Penetrating Peptides Derived from Protein Signal Sequences. International Journal of Molecular Sciences. 24(5). 4277–4277. 5 indexed citations
3.
Langel, Ülo, et al.. (2023). In Silico Studies to Support Vaccine Development. Pharmaceutics. 15(2). 654–654. 26 indexed citations
4.
Gestin, Maxime, et al.. (2020). Effect of small molecule signaling in PepFect14 transfection. PLoS ONE. 15(1). e0228189–e0228189. 4 indexed citations
5.
Gestin, Maxime, et al.. (2020). Mimicry of Dopamine 1 Receptor Signaling with Cell-Penetrating Peptides. International Journal of Peptide Research and Therapeutics. 27(1). 83–90. 3 indexed citations
6.
Cerrato, Carmine Pasquale, et al.. (2020). Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA coding mitochondrial proteins by cell-penetrating peptides. Journal of Materials Chemistry B. 8(47). 10825–10836. 27 indexed citations
7.
Hällbrink, Mattias, et al.. (2018). Cell-penetrating peptides for siRNA delivery to glioblastomas. Peptides. 104. 62–69. 57 indexed citations
8.
Arukuusk, Piret, Kaido Kurrikoff, Raivo Raid, et al.. (2017). Formulation of Stable and Homogeneous Cell-Penetrating Peptide NF55 Nanoparticles for Efficient Gene Delivery In Vivo. Molecular Therapy — Nucleic Acids. 10. 28–35. 21 indexed citations
9.
Regberg, Jakob, et al.. (2016). Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood–brain barrier model. International Journal of Pharmaceutics. 500(1-2). 128–135. 35 indexed citations
10.
Cerrato, Carmine Pasquale, Tõnis Lehto, & Ülo Langel. (2014). Peptide-based vectors: recent developments. BioMolecular Concepts. 5(6). 479–488. 22 indexed citations
11.
Hyvönen, Maija, Juulia Enbäck, Tuulia Huhtala, et al.. (2014). Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors. Molecular Cancer Therapeutics. 13(4). 996–1007. 44 indexed citations
12.
Langel, Ülo, et al.. (2013). Vectorization of splice-correcting oligonucleotides with cell-penetrating peptides. 31(2). 12–15. 3 indexed citations
13.
Lindgren, Maria & Ülo Langel. (2010). Classes and Prediction of Cell-Penetrating Peptides. Methods in molecular biology. 683. 3–19. 108 indexed citations
14.
Holm, Tina, Samir EL Andaloussi, & Ülo Langel. (2010). Comparison of CPP Uptake Methods. Methods in molecular biology. 683. 207–217. 17 indexed citations
15.
Lundin, Per, Henrik J. Johansson, Peter Guterstam, et al.. (2008). Distinct Uptake Routes of Cell-Penetrating Peptide Conjugates. Bioconjugate Chemistry. 19(12). 2535–2542. 151 indexed citations
16.
Jones, Sarah, Pernilla Östlund, Ülo Langel, et al.. (2006). A rhegnylogic strategy for the synthesis of signal transduction modulatory, cell penetrating peptides. Journal of Peptide Science. 3 indexed citations
17.
Brewer, Ariel, Ülo Langel, & John K. Robinson. (2005). Intracerebroventricular administration of galanin decreases free water intake and operant water reinforcer efficacy in water-restricted rats. Neuropeptides. 39(2). 117–124. 15 indexed citations
18.
Rezaei, Khadijeh, Isabella Shi Xu, Weiping Wu, et al.. (2001). Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord. Neuroreport. 12(2). 317–320. 31 indexed citations
19.
Mazarati, Andréy, Hantao Liu, Ursel Soomets, et al.. (1998). Galanin Modulation of Seizures and Seizure Modulation of Hippocampal Galanin in Animal Models of Status Epilepticus. Journal of Neuroscience. 18(23). 10070–10077. 149 indexed citations
20.
Bedecs, Katarina, Ülo Langel, & Tamás Bartfai. (1995). Metabolism of galanin and galanin (1–16) in isolated cerebrospinal fluid and spinal cord membranes from rat. Neuropeptides. 29(3). 137–143. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026